Proteomics in mutant KRAS Lung cancer

ABSTRACT: Proteomic studies to check the effect of MEK1/2 and KRAS G12C inhibitors in lung cancer cells

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Lung, Cell Culture

DISEASE(S): Lung Cancer

SUBMITTER: Enrique Santamaría  

LAB HEAD: Enrique Santamaria

PROVIDER: PXD024023 | Pride | 2023-08-22

REPOSITORIES: Pride